MetaCap

Cellebrite DI Ltd. (CLBT)

NASDAQ: CLBTTechnologyComputer Software: Prepackaged SoftwareUSD

10.77-0.55 (-4.86%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CLBT stock chart

Technical analysis

Key statistics

All statistics
52-week range
9.58 – 19.39
Day range
10.72 – 11.41
Volume / Avg
2.71M / 2.35M
Beta
—

52-week range

$9.58$19.39

CLBT stock today

Shares of Cellebrite DI (CLBT) finished lower on Nov 20 at $10.77, a drop of 4.86% or $0.55 per share, versus the S&P 500's 3.70% decline. Shares are 44.5% below their 52-week high of $19.39, set on Dec 22, 2025 and 12.4% above the 52-week low of $9.58, near the bottom of the past year's range. CLBT is down 40.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 36.2%.

At 43.1x trailing earnings, Cellebrite DI trades above the peer-group median of 26.7x. Its forward P/E of 16.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Cellebrite DI

Company profile

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency.

Industry
Computer Software: Prepackaged Software
CEO
Mr. Shiven Ramji
Headquarters
Petah Tikva
Employees
1,285

Financial highlights

Full financials

In fiscal 2025, Cellebrite DI generated $475.7 million in revenue, up 18.6% from fiscal 2024, its 6th consecutive year of revenue growth. Net income was $78.3 million, for a net margin of 16.5% versus a median of 3.0% in the prior 5 years. Gross margin was 84.2% (down from 84.4%) and operating margin 14.0%.

Cellebrite DI annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2022FY 2022FY 2021
Revenue$475.68M$401.20M$325.11M$270.65M$246.25M
Growth+18.56%+23.41%+20.12%+9.91%+26.34%
Net income$78.33M$-283.01M$-81.10M$120.81M$71.40M
EPS (diluted)$0.31$-1.35$-0.43$0.59$0.44

Analyst forecast

Forecast

Consensus (8 analysts)

strong_buy

Avg. price target

$15.43+43.27%

  • Strong buy 2
  • Buy 6
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $14.00High $20.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 12, 2026
EPS actual vs est.
$0.13 vs $0.12
Surprise
+8.33%

CLBT news

All CLBT news

Cellebrite DI peers

Technology sector
CLBT peer companies
CompanyPrice% ChgMarket capCompare
SPSCSPS Commerce Inc.76.88-0.36%$2.72Bvs CLBT
VERXVertex Inc. Class A17.23+0.29%$2.80Bvs CLBT
FSLYFastly Inc. Class A14.91-11.57%$2.40Bvs CLBT
MNDYmonday.com Ltd.72.16+3.23%$3.05Bvs CLBT
PRCHPorch Group Inc.19.88-0.40%$2.27Bvs CLBT
FRSHFreshworks Inc. Class A12.06-1.87%$3.16Bvs CLBT
ALRMAlarm.com Holdings Inc.64.99-0.61%$3.19Bvs CLBT
BLKBBlackbaud Inc.48.83-0.39%$2.20Bvs CLBT

Indexes, lists and sector

Cellebrite DI stock FAQ

What is Cellebrite DI's stock price today?

CLBT last traded at $10.77 as of Nov 20, 4:00 PM EST, down 4.86% on the day. Prices are delayed at least 15 minutes.

What is CLBT's P/E ratio?

CLBT trades at a trailing P/E ratio of 43.08 and a forward P/E of 16.09, compared with a median of 26.7 for its closest peers.

Who is Cellebrite DI's CEO?

Mr. Shiven Ramji is the chief executive officer of Cellebrite DI Ltd., which has about 1,285 employees.

What is the CLBT 52-week high?

The 52-week high for CLBT is $19.39 and the 52-week low is $9.58. The stock is currently 44.5% below its high.

Compare CLBT